Are These The Best Health Care Stocks To Buy In July 2021?
As the world continues to deal with the coronavirus and its variants of concern, healthcare services remain crucial. Likewise, health care stocks could also be worth watching in the stock market today. After all, the health care industry plays a vital role in developing, manufacturing, and marketing most of today’s medicines and cures. Because of the breadth of the industry, investors also have numerous points of entry as well. On one hand, we have biotech companies that produce the vaccines needed to fight pandemics across the globe. On the other hand, retail pharmacy operators would help consumers with their day-to-day health needs.
Earlier today, the World Health Organization (WHO) warned that a new wave of coronavirus could be on the horizon given the current spread of the delta variant. This comes just over a week after White House chief medical advisor Dr. Anthony Fauci shared a similar outlook. In the update, Dr. Fauci argued that the highly infectious delta variant could become the dominant strain in the U.S. soon. Fortunately, health care companies such as Johnson & Johnson (NYSE: JNJ) and CVS Health (NYSE: CVS) remain hard at work. In particular, JNJ’s coronavirus vaccine candidate received a positive update from U.S. Surgeon General Dr. Vivek Murthy, just yesterday. According to Dr. Murthy, the company’s vaccine could possibly protect against the delta variant. Given all of this, you might be keen on the health care industry yourself. Should that be the case, here are five names to know in the stock market now.
Top Health Care Stocks To Watch Right Now
- Trxade Health Inc. (NASDAQ: MEDS)
- Walgreens Boots Alliance Inc. (NASDAQ: WBA)
- Clover Health Investments Corporation (NASDAQ: CLOV)
- General Electric Company (NYSE: GE)
- Walmart Inc. (NYSE: WMT)
Trxade Health Inc.
Trxade is a health care stock that provides integrated pharmaceutical and medical services to pharmacies and consumers. It combines a web-based purchasing platform for supply chain transactions between pharmacies, drug distributors, and manufacturers. In essence, it provides a robust e-commerce technology platform that delivers buyer/seller pricing algorithms and data analytics features. MEDS stock currently trades at $6.67 a share as of 1:52 p.m. ET and has skyrocketed by over 70% on today’s opening bell. Investors could be responding to news that the company released today.
In detail, Trxade announced that its digital health care business subsidiary, Bonum Health, has signed a Telemedicine Service Distribution Deal with Big Y Pharmacy and Wellness Centers within their supermarkets in Massachusetts and Connecticut. Bonum Health will provide affordable telemedicine services to all patients of Big Y pharmacies by offering its signature Mobile Health Services and prescriber program. The partnership also provides Big Y patients direct access to prescription discount savings through Bonum Health. Given the excitement surrounding this piece of news, will you consider MEDS stock a buy?
Walgreens Boots Alliance Inc.
Walgreens is a pharmaceutical holding company. It owns the pharmacy chains Walgreens and Boots Walgreens and is a global leader in retail pharmacy. It can meet customer needs through its convenient retail locations and impressive digital platforms. Walgreens’ products impact millions of lives every day and the company boasts more than 170 years of trusted health care and innovation in community pharmacy. WBA stock currently trades at $49.78 as of 1:52 p.m. ET.
Today, the company reported stellar fiscal 2021 third-quarter results. Diving in, it posted sales of $34 billion, increasing by 12.1% year-over-year. It also reported earnings per share of $1.38 for the quarter. The company demonstrates continued momentum with its third-quarter results. It also says that it is in a strong position to grow and innovate its core retail and pharmacy business for the long run. It has also raised its full-year guidance to 10% growth in constant currency-adjusted EPS from continuing operations. With that in mind, will you consider adding WBA stock to your portfolio?
Clover Health Investments Corporation
Clover Health is an insurance company that offers next-generation health care technologies. In brief, it leverages its flagship software platform, the Clover Assistant, to provide America’s seniors with highly affordable health care plans. The company also empowers physicians with data-driven, personalized insights at the point of care, improving clinical decision-making and outcomes. CLOV stock currently trades at $12.52 as of 1:53 p.m. ET.
Last week, the company announced that it plans to expand into 101 new markets, nearly doubling its geographic footprint. The expansion, which is subject to CMS approval, will make Clover’s Medicare Advantage plans available to eligible individuals in over 200 counties across nine states in the U.S. “This expansion would allow more seniors—many of whom live in rural areas and are more likely to face health disparities than those in more urban areas—to access Clover’s high value, affordable, open network plans and data-driven, personalized care made possible by our clinical support tool, the Clover Assistant,” said Andrew Toy, President of Clover Health. All things considered, will you buy CLOV stock?
General Electric Company
General Electric, through its GE Healthcare segment, continues to deliver quality health care to communities. It does this especially by building intelligent devices, data analytics, applications, and services. The company is a leader in global medical technology and its products allow clinicians to make faster, more informed decisions. GE stock currently trades at $13.43 as of 1:53 p.m. ET.
Impressively, GE Healthcare continues to make massive strides in the industry. For starters, it is currently working with Congo’s Ministry of Health to help fight the pandemic in the region. This will see 82 sites around the country being equipped with GE’s mobile X-ray and ECG tech. Meanwhile, GE Healthcare also recently invested in five artificial intelligence-based health tech start-ups just last week. Overall, GE Healthcare appears to be expanding its operations internationally while investing in innovative tech as well. Given all of this, would you consider GE stock a top health care stock to watch now?
Most would not immediately think of multinational retailer Walmart when discussing health care. However, the company’s Walmart Pharmacy division does offer consumers a wide array of health care solutions. The likes of which consist of its $4 prescriptions, specialty pharmacy, flu shot, and pet medication services among others. Given Walmart’s immense presence across the globe, consumers could be turning to said services more. As it stands, WMT stock is currently trading at $139.77 a share as of 1:54 p.m. ET.
If anything, Walmart is not neglecting its pharmacy division while it grows its retail operations now. Starting this week, the company will be selling an exclusive private-label version of insulin, ReliOn NovoLog (RN). Notably, the key difference between RN and conventional insulin is the price tag. The price per vial of RN is $73 which is approximately $101 cheaper than a vial of branded insulin in the market today. Given that over 34 million people in the U.S. have diabetes, this is an outstanding move by Walmart. Would all this make WMT stock a top watch for you?